Showing results (381-390 of 548) with videos related to

Sort By:
Pageof 55
Frontiers in Public Health|April 23, 2024
Environmental factors and particle size shape the community structure of airborne total and pathogenic bacteria in a university campusTianer Zhang, Mengmeng Liu, Dalin Zhou, et al.
European Journal of Haematology|September 12, 2023
Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancyLiu Chen, Shuyi Ding, Yin Cheng, et al.
Life Sciences|January 1, 1997
Irreversible binding of N-methyl-N-[(1S)-1-(4-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl-3,4 -dichlorophenylacetamide to the cloned rat kappa opioid receptorC Chen, J Yin, J G Li, et al.
Experimental and Therapeutic Medicine|February 20, 2018
Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrestJun-Xiao Zhang, Hong Wei-Tan, Chun-Yan Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 15, 2019
Herbs-partitioned moxibustion improves intestinal epithelial tight junctions by upregulating A20 expression in a mouse model of Crohn's diseaseYin Shi, Yajing Guo, Jing Zhou, et al.
The Journal of Biological Chemistry|June 13, 1998
Isolation and characterization of thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cellsY Tong, X Liu-Chen, E A Ercikan-Abali, et al.
Journal for Immunotherapy of Cancer|March 3, 2023
Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinomaGang Xiao, Lifeng Li, Guilong Tanzhu, et al.
Journal of Environmental Management|September 3, 2024
Nano Fe3O4 improved the electron donating capacity of dissolved organic matter during sludge compostingLiu Chen, Zeyu Zhang, Rui Yang, et al.
Neurochemical Research|November 1, 1996
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivoX H Chen, L Y Liu-Chen, R J Tallarida, et al.
Brain Research|November 6, 2007
Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cellsPeng Huang, Wei Xu, Su-In Yoon, et al.
Pageof 55